Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The prognostic value of Her4 receptor isoform expression in triple-negative and Her2 positive breast cancer patients

24 Sept 2013

Abstract excerpt

BACKGROUND: Not only four but rather seven different human epidermal growth factor receptor related (Her) receptor tyrosine kinases (RTKs) have been described to be expressed in a variety of normal and neoplastic tissues: Her1, Her2, Her3, and additionally four Her4 isoforms have been identified. A differential expression of Her4 isoforms does not, however, play any role in either the molecular diagnostics or...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Advanced Breast Cancer Therapies
Share to Hedgehog Signaling Pathway Studies
Share to HER2/EGFR in Cancer Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 24063248
DOI: 10.1186/1471-2407-13-437

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 11 closest

The prognostic value of Her4 receptor isoform expression in triple-negative and Her2 positive breast cancer patientsPMID 24063248Read ↗

[Clinicopathological value of ER alpha, ER beta and those isoforms in breast cancer].Semantic proximity Read ↗

“Shedding” light on HER4 signaling in normal and malignant breast tissuesSemantic proximity Read ↗

Estrogen Receptor β Expression and Its Clinical Implication in Breast Cancers: Favorable or Unfavorable?Semantic proximity Read ↗

The diverse signaling network of EGFR, HER2, HER3 and HER4 tyrosine kinase receptors and the consequences for therapeutic approaches.Semantic proximity Read ↗

Quantification of HER family receptors in breast cancerSemantic proximity Read ↗

LMTK3 expression in breast cancer: association with tumor phenotype and clinical outcome.Semantic proximity Read ↗

Multichromatic phenotyping of HER receptor coexpression in breast tumor tissue samples using flow cytometry--possibilities and limitations.Semantic proximity Read ↗

CerbB2 status in breast cancer: pathologic issues.Semantic proximity Read ↗

Directing HER4 mRNA expression towards the CYT2 isoform by antisense oligonucleotide decreases growth of breast cancer cells in vitro and in vivoSemantic proximity Read ↗

Cytogenetic analysis of HER1/EGFR, HER2, HER3 and HER4 in 278 breast cancer patientsSemantic proximity Read ↗

Relationships between progesterone receptor isoforms and the HER/ErbB receptors and ligands network in 299 primary breast cancersSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.